Literature DB >> 6481169

The modulation of expression of polypeptide surface antigens on developing schistosomula of Schistosoma mansoni.

A J Simpson, G Payares, T Walker, M Knight, S R Smithers.   

Abstract

Five low m.w. polypeptide antigens are expressed on the surface of freshly transformed schistosomula of Schistosoma mansoni, and were reproducibly identified by surface labeling with 125I by using IODOGEN and immunoprecipitating with immune mouse sera. These molecules have approximate m.w. of 38,000, 32,000, 20,000, 17,000, and 15,000. They correspond to antigens recognized previously by lactoperoxidase-catalyzed iodination. Analysis of the surface of developing schistosomulum demonstrated that the 38,000 and 17,000 dalton antigens were lost from the parasite surface during 48 hr of in vitro culture. This process was not dependent on the presence of host serum. The two antigens were not lost due to shedding into the culture medium but were apparently sequestered to a site where they were no longer available for surface labeling. The 32,000, 20,000, and 15,000 dalton antigens, however, remained exposed on the schistosomulum surface for up to 2 days of in vitro culture. The expression of two new antigens was also induced by culture in vitro: a doublet of approximately 45,000 daltons and an antigen of approximately 11,000 daltons. The expression of the former was dependent on the presence of serum. These results demonstrate that the development of the schistosomula surface is a complex process, with events both dependent and independent of the presence of serum. In addition, the expression of polypeptide antigens is not coordinated, and antigens are lost, retained, or appear on the schistosomulum surface during the early stages of maturation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481169

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Cloning of a cDNA encoding a surface antigen of Schistosoma mansoni schistosomula recognized by sera of vaccinated mice.

Authors:  J P Dalton; T D Tom; M Strand
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

2.  Resistance induced by drug abbreviated Schistosoma mansoni infections: treatment with the drug Ro11-3128 leads to enhanced antigen presentation.

Authors:  D A Smith; Q D Bickle; P M Kaye
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

3.  Human monocyte-derived macrophages are lysed by schistosomula of Schistosoma mansoni and fail to kill the parasite after activation with interferon gamma.

Authors:  H G Remold; A Mednis; A Hein; J P Caulfield
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

Review 4.  Glycoconjugates in host-helminth interactions.

Authors:  Nina Salinger Prasanphanich; Megan L Mickum; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Front Immunol       Date:  2013-08-28       Impact factor: 7.561

Review 5.  Deciphering the glycogenome of schistosomes.

Authors:  Megan L Mickum; Nina S Prasanphanich; Jamie Heimburg-Molinaro; Kristoffer E Leon; Richard D Cummings
Journal:  Front Genet       Date:  2014-08-05       Impact factor: 4.599

6.  Comparative sequence analysis reveals regulation of genes in developing schistosomula of Schistosoma mansoni exposed to host portal serum.

Authors:  Wander de Jesus Jeremias; Flávio Marcos Gomes Araújo; Fábio Ribeiro Queiroz; Fabiano Sviatopolk Mirsky Pais; Ana Carolina Alves de Mattos; Anna Christina de Matos Salim; Paulo Marcos Zech Coelho; Guilherme Correa Oliveira; John Robert Kusel; Renata Guerra-Sá; Roney Santos Coimbra; Élio Hideo Babá
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

7.  Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes.

Authors:  Geoffrey N Gobert; Mai H Tran; Luke Moertel; Jason Mulvenna; Malcolm K Jones; Donald P McManus; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09

Review 8.  Biomphalaria glabrata immunity: Post-genome advances.

Authors:  Maria G Castillo; Judith E Humphries; Marina M Mourão; Joshua Marquez; Adrian Gonzalez; Cesar E Montelongo
Journal:  Dev Comp Immunol       Date:  2019-11-21       Impact factor: 3.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.